| High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing CD Sago, MP Lokugamage, K Paunovska, DA Vanover, CM Monaco, ... Proceedings of the National Academy of Sciences 115 (42), E9944-E9952, 2018 | 259 | 2018 |
| A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation K Paunovska, CD Sago, CM Monaco, WH Hudson, MG Castro, ... Nano letters 18 (3), 2148-2157, 2018 | 186 | 2018 |
| Nanoparticles containing oxidized cholesterol deliver mRNA to the liver microenvironment at clinically relevant doses K Paunovska, AJ Da Silva Sanchez, CD Sago, Z Gan, MP Lokugamage, ... Advanced materials 31 (14), 1807748, 2019 | 160 | 2019 |
| Constrained nanoparticles deliver siRNA and sgRNA to T cells in vivo without targeting ligands MP Lokugamage, CD Sago, Z Gan, BR Krupczak, JE Dahlman Advanced Materials 31 (41), 1902251, 2019 | 121 | 2019 |
| Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery K Paunovska, CJ Gil, MP Lokugamage, CD Sago, M Sato, GN Lando, ... ACS nano 12 (8), 8341-8349, 2018 | 119 | 2018 |
| Nanoparticles that deliver RNA to bone marrow identified by in vivo directed evolution CD Sago, MP Lokugamage, FZ Islam, BR Krupczak, M Sato, JE Dahlman Journal of the American Chemical Society 140 (49), 17095-17105, 2018 | 103 | 2018 |
| Mild innate immune activation overrides efficient nanoparticle‐mediated RNA delivery MP Lokugamage, Z Gan, C Zurla, J Levin, FZ Islam, S Kalathoor, M Sato, ... Advanced materials 32 (1), 1904905, 2020 | 97 | 2020 |
| Testing thousands of nanoparticles in vivo using DNA barcodes MP Lokugamage, CD Sago, JE Dahlman Current Opinion in Biomedical Engineering 7, 1-8, 2018 | 72 | 2018 |
| Using large datasets to understand nanotechnology K Paunovska, D Loughrey, CD Sago, R Langer, JE Dahlman Advanced Materials 31 (43), 1902798, 2019 | 63 | 2019 |
| Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver CD Sago, MP Lokugamage, D Loughrey, KE Lindsay, R Hincapie, ... Nature biomedical engineering 6 (2), 157-167, 2022 | 45 | 2022 |
| Modifying a commonly expressed endocytic receptor retargets nanoparticles in vivo CD Sago, MP Lokugamage, GN Lando, N Djeddar, NN Shah, C Syed, ... Nano letters 18 (12), 7590-7600, 2018 | 44 | 2018 |
| Cell subtypes within the liver microenvironment differentially interact with lipid nanoparticles CD Sago, BR Krupczak, MP Lokugamage, Z Gan, JE Dahlman Cellular and Molecular Bioengineering 12, 389-397, 2019 | 40 | 2019 |
| High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo SG Huayamares, MP Lokugamage, R Rab, AJDS Sanchez, H Kim, ... Journal of Controlled Release 357, 394-403, 2023 | 24 | 2023 |
| Barcoding chemical modifications into nucleic acids improves drug stability in vivo CD Sago, S Kalathoor, JP Fitzgerald, GN Lando, N Djeddar, AV Bryksin, ... Journal of Materials Chemistry B 6 (44), 7197-7203, 2018 | 20 | 2018 |
| Screening of chemically distinct lipid nanoparticles in vivo using DNA barcoding technology towards effectively delivering messenger RNA to hematopoietic stem and progenitor cells C Sago, E Campbell, B Lutz, N Patwardhan, G Hamilton, C Wong, D Lee, ... Blood 138, 2931, 2021 | 4 | 2021 |
| Nanomaterials GL Hamilton, NN Patwardhan, CD Sago, MFG Shehata, MB Chhabra US Patent App. 17/142,595, 2021 | 2 | 2021 |
| Nanomaterials comprising ester-linked acetals NN Patwardhan, GL Hamilton, CD Sago, MF Shehata, MB Chhabra, ... US Patent App. 18/211,857, 2023 | 1 | 2023 |
| Nanomaterials containing constrained lipids and uses thereof JE Dahlman, CD Sago, Z Gan US Patent App. 17/630,861, 2022 | 1 | 2022 |
| Nanomaterials comprising a biodegradable feature MF Shehata, NN Patwardhan, GL Hamilton, CD Sago, MB Chhabra US Patent App. 17/579,150, 2022 | 1 | 2022 |
| Multiplexed Analysis of Materials for Tissue Delivery J Dahlman, S Cory, M Lokugamage US Patent App. 16/753,241, 2020 | 1 | 2020 |
James E. DahlmanEmory School of Medicine / Georgia Tech在 emory.edu 的电子邮件经过验证
